Funded Startups in Cambridgeshire
Cambridge dominates the Cambridgeshire funding landscape, with 47 of the 50 most recent rounds headquartered in the city — Paragraf (Somersham) and Haddenh…
Cambridge dominates the Cambridgeshire funding landscape, with 47 of the 50 most recent rounds headquartered in the city — Paragraf (Somersham) and Haddenham-based Infinity Market Ltd and Vizzy are the only outliers. Biotechnology is the defining sector: 18 of the 50 companies operate in the space, anchored by CellCentric's $120M Series C in May 2025 and Artios Pharma's $115M Series D in November 2025. Three additional companies — Nuclera, Luminance, and Riverlane — each closed $75M Series C rounds between August 2024 and February 2025, a concentration of large growth-stage deals unusual for a single regional cluster.
Artificial intelligence adds seven companies to the mix, including Shift Bioscience ($16M Seed, October 2024) and Luminance ($75M Series C, February 2025). Round stages span from Sortera Bio's $10M pre-seed in June 2025 to Owlstone Medical's $27M Series E in January 2025, with hardware, energy, and health care each contributing multiple deals alongside the dominant biotech and AI cohorts.
Most recent rounds
50 shownRelated listings
Frequently asked
What are the largest disclosed rounds among recently funded Cambridgeshire startups?
The top three are CellCentric ($120M Series C, May 2025), Artios Pharma ($115M Series D, November 2025), and a three-way tie at $75M between Nuclera (Series C, October 2024), Luminance (Series C, February 2025), and Riverlane (Series C, August 2024). NRG Therapeutics ($68M Series B, September 2025) and Paragraf ($55M Series C, August 2025) are the next largest disclosed deals in this set.
Which sector receives the most funding in Cambridgeshire?
Biotechnology accounts for 18 of the 50 companies shown, with disclosed rounds ranging from Tagomics' $1M to CellCentric's $120M Series C. Artificial intelligence is the second most active sector with seven companies, including Healx, Shift Bioscience, and Luminance.
Are most funded Cambridgeshire startups based in Cambridge city itself?
Yes — 47 of the 50 companies list Cambridge as their city. The three exceptions are Paragraf (Somersham, $55M Series C), Infinity Market Ltd (Haddenham, $100K Seed), and Vizzy (Haddenham, $5M Seed).
How prevalent are Series C rounds compared to other named stages?
Series C is the most common named stage in this dataset, with seven companies closing at that level: Paragraf, CellCentric, Cambridge GaN Devices, Luminance, Natrox, Nuclera, and Riverlane. Seed rounds follow with 11 companies, indicating the region sustains both entry-level and growth-stage capital flows simultaneously.
What sectors beyond biotech and AI are attracting capital in Cambridgeshire?
Hardware makes a notable showing — Cambridge GaN Devices ($32M Series C), Forefront RF ($21M Series A), and VividQ ($7M Series A) all closed within this period. Energy is represented by Nyobolt ($30M), Echion Technologies ($13M), and illumion ($3M Seed), while health care features Natrox ($33M Series C) and Owlstone Medical ($27M Series E).
Is there meaningful early-stage activity in Cambridgeshire, or do most deals skew later-stage?
Early-stage activity is substantial: 11 of the 50 rounds are Seed and Sortera Bio closed a $10M pre-seed as recently as June 2025. Several additional rounds carry undisclosed amounts with unspecified stages — Broken String Biosciences, Healx, and Microbiotica among them — suggesting seed-level deal flow that is not fully captured in public disclosures.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.